Vicarious Surgical shares surge 18.43% intraday as outsourcing software execution aims to cut costs and accelerate clinical timelines.

Vicarious Surgical surged 18.43% intraday after disclosing a strategic shift to outsource software execution to control costs and accelerate clinical timelines. The announcement, tied to its surgical robotics and medical device development, emphasized streamlined operations and faster progress toward clinical trials and FDA approval. The move signals improved efficiency in its MedTech strategy, aligning with investor optimism around cost management and regulatory milestones in the competitive robotic surgery sector.